| Addiphos concentrate for solution for infusion PA2059/024/001 |
Potassium dihydrogen phosphate, Potassium hydroxide, Disodium phosphate dihydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Additrace N concentrate for solution for infusion PA2059/023/002 |
Chromic chloride hexahydrate, Copper chloride dihydrate, Ferric chloride hexahydrate, Manganese chloride tetrahydrate, Potassium iodide |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Adenosine 3 mg/ml solution for injection in pre-filled syringe PA2059/004/001 |
Adenosine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Amikacin 5 mg/ml solution for infusion PA2059/072/001 |
Amikacin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Aminoven 16 solution for infusion, bottle PA2059/025/002 |
Isoleucine, Leucine, Lysine acetate, Methionine, Phenylalanine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Aminoven 25 solution for infusion, bottle PA2059/025/003 |
Isoleucine, Leucine, Lysine acetate, Methionine, Phenylalanine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Aminoven 8 solution for infusion, bottle PA2059/025/001 |
Isoleucine, Leucine, Lysine acetate, Methionine, Phenylalanine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Azacitidine Kabi 25 mg/mL powder for suspension for injection EU/1/23/1777/001 |
Azacitidine |
Fresenius Kabi Deutschland GmbH |
— |
| Bendamustine HCl 100 mg Powder for Concentrate for Solution for Infusion PA2059/028/002 |
Bendamustine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Bendamustine HCl 25 mg Powder for Concentrate for Solution for Infusion PA2059/028/001 |
Bendamustine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Benzylpenicillin sodium 1200 mg powder for solution for injection/infusion PA2059/085/002 |
Benzylpenicillin Sodium |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Benzylpenicillin sodium 600 mg powder for solution for injection/infusion PA2059/085/001 |
Benzylpenicillin Sodium |
Fresenius Kabi Deutschland GmbH |
Marketed |
| BOMYNTRA 120 mg solution for injection in pre-filled syringe EU/1/25/1953/04-06 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| BOMYNTRA 120 mg solution for injection in vial EU/1/25/1953/01-03 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| Bortezomib Fresenius Kabi 3.5 mg powder for solution for injection EU/1/19/1397/001 |
Bortezomib |
Fresenius Kabi Deutschland GmbH |
— |
| Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion EU/1/14/951/001 |
Busulfan |
Fresenius Kabi Deutschland GmbH |
— |
| Cabazitaxel Fresenius Kabi 20 mg/ml concentrate for solution for infusion PA2059/082/001 |
Cabazitaxel |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Calrecia 100 mmol/l, solution for infusion PA1350/006/001 |
Calcium chloride dihydrate |
Fresenius Medical Care Deutschland GmbH |
Marketed |
| Carboplatin 10 mg/ml concentrate for solution for infusion PA2059/032/001 |
Carboplatin |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Cefuroxime 1.5 g powder for solution for injection/infusion PA2059/006/002 |
Cefuroxime Sodium |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Cefuroxime 750 mg powder for solution for injection/infusion PA2059/006/001 |
Cefuroxime Sodium |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Cifoban 136 mmol/l solution for infusion PA1350/008/001 |
Trisodium citrate dihydrate |
Fresenius Medical Care Deutschland GmbH |
Not marketed |
| Clindamycin 150 mg/ml solution for injection PA2059/007/001 |
CLINDAMYCIN PHOSPHATE |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Co-amoxiclav 1000mg/200mg powder for solution for injection/infusion PA2059/026/001 |
Amoxicillin, Clavulanic acid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Conexxence 60 mg solution for injection in pre-filled syringe EU/1/25/1954/01 |
Denosumab |
Fresenius Kabi Deutschland GmbH |
— |
| Cytarabine 100 mg/ml Solution for Injection or Infusion PA2059/034/001 |
Cytarabine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Dexamethasone phosphate 4 mg/ml solution for injection PA2059/077/001 |
Dexamethasone sodium phosphate |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Dexmedetomidine Kabi 100 microgram/mL concentrate for solution for infusion PA2059/076/001 |
Dexmedetomidine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Dipeptiven, concentrate for solution for infusion PA0697/002/001 |
L-alanyl-l glutamine |
Fresenius AG |
Not marketed |
| DOCETAXEL KABI 120 mg/6 ml concentrate for solution for infusion EU/1/12/770/002 |
Docetaxel |
Fresenius Kabi Deutschland GmbH |
— |
| DOCETAXEL KABI 160 mg/8 ml concentrate for solution for infusion EU/1/12/770/003 |
Docetaxel |
Fresenius Kabi Deutschland GmbH |
— |
| DOCETAXEL KABI 180 mg/9 ml concentrate for solution for infusion EU/1/12/770/004 |
Docetaxel |
Fresenius Kabi Deutschland GmbH |
— |
| DOCETAXEL KABI 80 mg/4 ml concentrate for solution for infusion EU/1/12/770/001 |
Docetaxel |
Fresenius Kabi Deutschland GmbH |
— |
| Ephedrine Kabi 10 mg/mL solution for injection PA2059/086/002 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 3 mg/mL solution for injection PA2059/086/001 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ephedrine Kabi 30 mg/mL solution for injection PA2059/086/003 |
Ephedrine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Etoposide 20 mg/ml concentrate for solution for infusion PA2059/036/001 |
Etoposide |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Flucloxacillin 1000 mg powder for solution for injection/infusion PA2059/069/002 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Flucloxacillin 2000 mg powder for solution for injection/infusion PA2059/069/003 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Flucloxacillin 500 mg powder for solution for injection/infusion PA2059/069/001 |
FLUCLOXACILLIN SODIUM |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Folinic acid (as calcium folinate) 10 mg/ml solution for injection or infusion PA2059/001/001 |
Folinic acid |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Furosemide 20 mg/2 ml solution for injection/infusion PA2059/038/001 |
Furosemide |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Geloplasma Solution for Infusion (Polyolefine/Freeflex Bag) PA2059/008/002 |
Modified liquid gelatine, Sodium chloride, Magnesium chloride hexahydrate, Potassium chloride, Sodium (s)-lactate solution |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Geloplasma, Solution for Infusion PA2059/008/001 |
Modified liquid gelatine, Sodium chloride, Magnesium chloride hexahydrate, Potassium chloride, Sodium lactate solution |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Gemcitabine 1 g powder for solution for infusion PA2059/039/002 |
Gemcitabine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Gemcitabine 2 g powder for solution for infusion PA2059/039/003 |
Gemcitabine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Gemcitabine 200 mg powder for solution for infusion PA2059/039/001 |
Gemcitabine |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Gemcitabine 38 mg/ml Concentrate for Solution for Infusion PA2059/039/005 |
Gemcitabine hydrochloride |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Glucose 10% w/v Solution for Infusion PA2059/040/005 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Glucose 10% w/v Solution for Infusion PA2059/040/006 |
Glucose anhydrous |
Fresenius Kabi Deutschland GmbH |
Not marketed |